Baidu
map
BMC CANCER 润色咨询

BMC CANCER

出版年份：2001 年文章数：12290 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：1.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2216888, encodeId=e076221688892, content=请问为啥送审回来修订以后还是只给传一个文稿文件，修订后不是得传修订版和最终版俩文件嘛，求怎么解决.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4d59144649, createdName=ms8000001805085068, createdTime=Thu Jul 25 22:43:38 CST 2024, time=2024-07-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216756, encodeId=881b2216e5652, content=请问现在是不能投稿了吗，为什么进不去提交不了？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a39b2533900, createdName=1250939fm47暂无昵称, createdTime=Thu Jul 25 11:01:29 CST 2024, time=2024-07-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2213777, encodeId=22ef2213e7716, content=请问总共会邀请几个审稿人呀？我的第2个审稿人同意审稿了3个月都没回意见，今天又邀请了第3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4c1b5295017, createdName=14870713m77暂无昵称, createdTime=Sun Jul 07 22:14:44 CST 2024, time=2024-07-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216151, encodeId=69df22161511b, content=偏重的研究方向：生信<br>经验分享：显示两个人审都审完了快1个多月了，一直没后续，催了编辑也没用……咋整, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=frontiers, createdTime=Sun Jul 21 21:21:22 CST 2024, time=2024-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：影像组学;乳腺癌;病理组学<br>经验分享：<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了 同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212942, encodeId=62322212942b2, content=请问peer review期间系统时间变来变去什么意思呢，7 Jun为送外审日期，29 Jun变了一次，第二天又变成7 Jun了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e76402381, createdName=小小猫豆小豆, createdTime=Wed Jul 03 11:03:16 CST 2024, time=2024-07-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2212037, encodeId=08c7221203ebd, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：胰腺癌;标志物<br>经验分享：等的我延毕了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23b46513441, createdName=ms5000000153023119, createdTime=Fri Jun 28 07:32:17 CST 2024, time=2024-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床<br>经验分享：1月5日 peer review到现在5个月状态一直没变 中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省)]
    2024-07-25 ms8000001805085068 来自浙江省

    请问为啥送审回来修订以后还是只给传一个文稿文件，修订后不是得传修订版和最终版俩文件嘛，求怎么解决..

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2216888, encodeId=e076221688892, content=请问为啥送审回来修订以后还是只给传一个文稿文件，修订后不是得传修订版和最终版俩文件嘛，求怎么解决.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4d59144649, createdName=ms8000001805085068, createdTime=Thu Jul 25 22:43:38 CST 2024, time=2024-07-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216756, encodeId=881b2216e5652, content=请问现在是不能投稿了吗，为什么进不去提交不了？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a39b2533900, createdName=1250939fm47暂无昵称, createdTime=Thu Jul 25 11:01:29 CST 2024, time=2024-07-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2213777, encodeId=22ef2213e7716, content=请问总共会邀请几个审稿人呀？我的第2个审稿人同意审稿了3个月都没回意见，今天又邀请了第3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4c1b5295017, createdName=14870713m77暂无昵称, createdTime=Sun Jul 07 22:14:44 CST 2024, time=2024-07-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216151, encodeId=69df22161511b, content=偏重的研究方向：生信<br>经验分享：显示两个人审都审完了快1个多月了，一直没后续，催了编辑也没用……咋整, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=frontiers, createdTime=Sun Jul 21 21:21:22 CST 2024, time=2024-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：影像组学;乳腺癌;病理组学<br>经验分享：<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了 同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212942, encodeId=62322212942b2, content=请问peer review期间系统时间变来变去什么意思呢，7 Jun为送外审日期，29 Jun变了一次，第二天又变成7 Jun了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e76402381, createdName=小小猫豆小豆, createdTime=Wed Jul 03 11:03:16 CST 2024, time=2024-07-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2212037, encodeId=08c7221203ebd, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：胰腺癌;标志物<br>经验分享：等的我延毕了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23b46513441, createdName=ms5000000153023119, createdTime=Fri Jun 28 07:32:17 CST 2024, time=2024-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床<br>经验分享：1月5日 peer review到现在5个月状态一直没变 中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省)]
    2024-07-25 1250939fm47暂无昵称 来自河南省

    请问现在是不能投稿了吗，为什么进不去提交不了？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2216888, encodeId=e076221688892, content=请问为啥送审回来修订以后还是只给传一个文稿文件，修订后不是得传修订版和最终版俩文件嘛，求怎么解决.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4d59144649, createdName=ms8000001805085068, createdTime=Thu Jul 25 22:43:38 CST 2024, time=2024-07-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216756, encodeId=881b2216e5652, content=请问现在是不能投稿了吗，为什么进不去提交不了？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a39b2533900, createdName=1250939fm47暂无昵称, createdTime=Thu Jul 25 11:01:29 CST 2024, time=2024-07-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2213777, encodeId=22ef2213e7716, content=请问总共会邀请几个审稿人呀？我的第2个审稿人同意审稿了3个月都没回意见，今天又邀请了第3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4c1b5295017, createdName=14870713m77暂无昵称, createdTime=Sun Jul 07 22:14:44 CST 2024, time=2024-07-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216151, encodeId=69df22161511b, content=偏重的研究方向：生信<br>经验分享：显示两个人审都审完了快1个多月了，一直没后续，催了编辑也没用……咋整, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=frontiers, createdTime=Sun Jul 21 21:21:22 CST 2024, time=2024-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：影像组学;乳腺癌;病理组学<br>经验分享：<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了 同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212942, encodeId=62322212942b2, content=请问peer review期间系统时间变来变去什么意思呢，7 Jun为送外审日期，29 Jun变了一次，第二天又变成7 Jun了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e76402381, createdName=小小猫豆小豆, createdTime=Wed Jul 03 11:03:16 CST 2024, time=2024-07-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2212037, encodeId=08c7221203ebd, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：胰腺癌;标志物<br>经验分享：等的我延毕了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23b46513441, createdName=ms5000000153023119, createdTime=Fri Jun 28 07:32:17 CST 2024, time=2024-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床<br>经验分享：1月5日 peer review到现在5个月状态一直没变 中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省)]
    2024-07-07 14870713m77暂无昵称 来自广东省

    请问总共会邀请几个审稿人呀？我的第2个审稿人同意审稿了3个月都没回意见，今天又邀请了第3个审稿人。

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2216888, encodeId=e076221688892, content=请问为啥送审回来修订以后还是只给传一个文稿文件，修订后不是得传修订版和最终版俩文件嘛，求怎么解决.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4d59144649, createdName=ms8000001805085068, createdTime=Thu Jul 25 22:43:38 CST 2024, time=2024-07-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216756, encodeId=881b2216e5652, content=请问现在是不能投稿了吗，为什么进不去提交不了？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a39b2533900, createdName=1250939fm47暂无昵称, createdTime=Thu Jul 25 11:01:29 CST 2024, time=2024-07-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2213777, encodeId=22ef2213e7716, content=请问总共会邀请几个审稿人呀？我的第2个审稿人同意审稿了3个月都没回意见，今天又邀请了第3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4c1b5295017, createdName=14870713m77暂无昵称, createdTime=Sun Jul 07 22:14:44 CST 2024, time=2024-07-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216151, encodeId=69df22161511b, content=偏重的研究方向：生信<br>经验分享：显示两个人审都审完了快1个多月了，一直没后续，催了编辑也没用……咋整, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=frontiers, createdTime=Sun Jul 21 21:21:22 CST 2024, time=2024-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：影像组学;乳腺癌;病理组学<br>经验分享：<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了 同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212942, encodeId=62322212942b2, content=请问peer review期间系统时间变来变去什么意思呢，7 Jun为送外审日期，29 Jun变了一次，第二天又变成7 Jun了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e76402381, createdName=小小猫豆小豆, createdTime=Wed Jul 03 11:03:16 CST 2024, time=2024-07-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2212037, encodeId=08c7221203ebd, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：胰腺癌;标志物<br>经验分享：等的我延毕了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23b46513441, createdName=ms5000000153023119, createdTime=Fri Jun 28 07:32:17 CST 2024, time=2024-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床<br>经验分享：1月5日 peer review到现在5个月状态一直没变 中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省)]
    2024-07-21 frontiers 来自重庆

    偏重的研究方向：生信
    经验分享：显示两个人审都审完了快1个多月了，一直没后续，催了编辑也没用……咋整

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2216888, encodeId=e076221688892, content=请问为啥送审回来修订以后还是只给传一个文稿文件，修订后不是得传修订版和最终版俩文件嘛，求怎么解决.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4d59144649, createdName=ms8000001805085068, createdTime=Thu Jul 25 22:43:38 CST 2024, time=2024-07-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216756, encodeId=881b2216e5652, content=请问现在是不能投稿了吗，为什么进不去提交不了？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a39b2533900, createdName=1250939fm47暂无昵称, createdTime=Thu Jul 25 11:01:29 CST 2024, time=2024-07-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2213777, encodeId=22ef2213e7716, content=请问总共会邀请几个审稿人呀？我的第2个审稿人同意审稿了3个月都没回意见，今天又邀请了第3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4c1b5295017, createdName=14870713m77暂无昵称, createdTime=Sun Jul 07 22:14:44 CST 2024, time=2024-07-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216151, encodeId=69df22161511b, content=偏重的研究方向：生信<br>经验分享：显示两个人审都审完了快1个多月了，一直没后续，催了编辑也没用……咋整, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=frontiers, createdTime=Sun Jul 21 21:21:22 CST 2024, time=2024-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：影像组学;乳腺癌;病理组学<br>经验分享：<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了 同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212942, encodeId=62322212942b2, content=请问peer review期间系统时间变来变去什么意思呢，7 Jun为送外审日期，29 Jun变了一次，第二天又变成7 Jun了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e76402381, createdName=小小猫豆小豆, createdTime=Wed Jul 03 11:03:16 CST 2024, time=2024-07-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2212037, encodeId=08c7221203ebd, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：胰腺癌;标志物<br>经验分享：等的我延毕了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23b46513441, createdName=ms5000000153023119, createdTime=Fri Jun 28 07:32:17 CST 2024, time=2024-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床<br>经验分享：1月5日 peer review到现在5个月状态一直没变 中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省)]
    2023-04-06 YG社长候选人 来自四川省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：影像组学;乳腺癌;病理组学
    经验分享：
    Submission accepted
    06 Apr 2023
    Submission under peer review
    23 Mar 2023
    Submission passed technical check
    23 Mar 2023
    Amendment received
    23 Mar 2023
    Revision received
    23 Mar 2023
    Submission under peer review
    01 Mar 2023
    Technical check
    Submission passed technical check
    01 Mar 2023
    Amendment received
    25 Feb 2023
    Amendment received
    22 Feb 2023
    Submission is under technical check
    15 Feb 2023
    Submission received
    15 Feb 2023
    刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了 同行评审只用了10天左右，以上是我的时间路径供大家参考。

    8

    展开8条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2216888, encodeId=e076221688892, content=请问为啥送审回来修订以后还是只给传一个文稿文件，修订后不是得传修订版和最终版俩文件嘛，求怎么解决.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4d59144649, createdName=ms8000001805085068, createdTime=Thu Jul 25 22:43:38 CST 2024, time=2024-07-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216756, encodeId=881b2216e5652, content=请问现在是不能投稿了吗，为什么进不去提交不了？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a39b2533900, createdName=1250939fm47暂无昵称, createdTime=Thu Jul 25 11:01:29 CST 2024, time=2024-07-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2213777, encodeId=22ef2213e7716, content=请问总共会邀请几个审稿人呀？我的第2个审稿人同意审稿了3个月都没回意见，今天又邀请了第3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4c1b5295017, createdName=14870713m77暂无昵称, createdTime=Sun Jul 07 22:14:44 CST 2024, time=2024-07-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216151, encodeId=69df22161511b, content=偏重的研究方向：生信<br>经验分享：显示两个人审都审完了快1个多月了，一直没后续，催了编辑也没用……咋整, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=frontiers, createdTime=Sun Jul 21 21:21:22 CST 2024, time=2024-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：影像组学;乳腺癌;病理组学<br>经验分享：<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了 同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212942, encodeId=62322212942b2, content=请问peer review期间系统时间变来变去什么意思呢，7 Jun为送外审日期，29 Jun变了一次，第二天又变成7 Jun了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e76402381, createdName=小小猫豆小豆, createdTime=Wed Jul 03 11:03:16 CST 2024, time=2024-07-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2212037, encodeId=08c7221203ebd, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：胰腺癌;标志物<br>经验分享：等的我延毕了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23b46513441, createdName=ms5000000153023119, createdTime=Fri Jun 28 07:32:17 CST 2024, time=2024-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床<br>经验分享：1月5日 peer review到现在5个月状态一直没变 中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省)]
    2024-07-03 小小猫豆小豆 来自上海

    请问peer review期间系统时间变来变去什么意思呢，7 Jun为送外审日期，29 Jun变了一次，第二天又变成7 Jun了……

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2216888, encodeId=e076221688892, content=请问为啥送审回来修订以后还是只给传一个文稿文件，修订后不是得传修订版和最终版俩文件嘛，求怎么解决.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4d59144649, createdName=ms8000001805085068, createdTime=Thu Jul 25 22:43:38 CST 2024, time=2024-07-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216756, encodeId=881b2216e5652, content=请问现在是不能投稿了吗，为什么进不去提交不了？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a39b2533900, createdName=1250939fm47暂无昵称, createdTime=Thu Jul 25 11:01:29 CST 2024, time=2024-07-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2213777, encodeId=22ef2213e7716, content=请问总共会邀请几个审稿人呀？我的第2个审稿人同意审稿了3个月都没回意见，今天又邀请了第3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4c1b5295017, createdName=14870713m77暂无昵称, createdTime=Sun Jul 07 22:14:44 CST 2024, time=2024-07-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216151, encodeId=69df22161511b, content=偏重的研究方向：生信<br>经验分享：显示两个人审都审完了快1个多月了，一直没后续，催了编辑也没用……咋整, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=frontiers, createdTime=Sun Jul 21 21:21:22 CST 2024, time=2024-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：影像组学;乳腺癌;病理组学<br>经验分享：<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了 同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212942, encodeId=62322212942b2, content=请问peer review期间系统时间变来变去什么意思呢，7 Jun为送外审日期，29 Jun变了一次，第二天又变成7 Jun了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e76402381, createdName=小小猫豆小豆, createdTime=Wed Jul 03 11:03:16 CST 2024, time=2024-07-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2212037, encodeId=08c7221203ebd, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：胰腺癌;标志物<br>经验分享：等的我延毕了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23b46513441, createdName=ms5000000153023119, createdTime=Fri Jun 28 07:32:17 CST 2024, time=2024-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床<br>经验分享：1月5日 peer review到现在5个月状态一直没变 中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省)]
    2023-04-23 1479422cm92暂无昵称 来自青海省

    纯生信的文章不知道是不是接受

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2216888, encodeId=e076221688892, content=请问为啥送审回来修订以后还是只给传一个文稿文件，修订后不是得传修订版和最终版俩文件嘛，求怎么解决.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4d59144649, createdName=ms8000001805085068, createdTime=Thu Jul 25 22:43:38 CST 2024, time=2024-07-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216756, encodeId=881b2216e5652, content=请问现在是不能投稿了吗，为什么进不去提交不了？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a39b2533900, createdName=1250939fm47暂无昵称, createdTime=Thu Jul 25 11:01:29 CST 2024, time=2024-07-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2213777, encodeId=22ef2213e7716, content=请问总共会邀请几个审稿人呀？我的第2个审稿人同意审稿了3个月都没回意见，今天又邀请了第3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4c1b5295017, createdName=14870713m77暂无昵称, createdTime=Sun Jul 07 22:14:44 CST 2024, time=2024-07-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216151, encodeId=69df22161511b, content=偏重的研究方向：生信<br>经验分享：显示两个人审都审完了快1个多月了，一直没后续，催了编辑也没用……咋整, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=frontiers, createdTime=Sun Jul 21 21:21:22 CST 2024, time=2024-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：影像组学;乳腺癌;病理组学<br>经验分享：<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了 同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212942, encodeId=62322212942b2, content=请问peer review期间系统时间变来变去什么意思呢，7 Jun为送外审日期，29 Jun变了一次，第二天又变成7 Jun了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e76402381, createdName=小小猫豆小豆, createdTime=Wed Jul 03 11:03:16 CST 2024, time=2024-07-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2212037, encodeId=08c7221203ebd, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：胰腺癌;标志物<br>经验分享：等的我延毕了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23b46513441, createdName=ms5000000153023119, createdTime=Fri Jun 28 07:32:17 CST 2024, time=2024-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床<br>经验分享：1月5日 peer review到现在5个月状态一直没变 中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省)]
    2024-06-28 ms5000000153023119 来自北京

    审稿速度:6.0 | 投稿命中率:75.0
    偏重的研究方向：胰腺癌;标志物
    经验分享：等的我延毕了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2216888, encodeId=e076221688892, content=请问为啥送审回来修订以后还是只给传一个文稿文件，修订后不是得传修订版和最终版俩文件嘛，求怎么解决.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4d59144649, createdName=ms8000001805085068, createdTime=Thu Jul 25 22:43:38 CST 2024, time=2024-07-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216756, encodeId=881b2216e5652, content=请问现在是不能投稿了吗，为什么进不去提交不了？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a39b2533900, createdName=1250939fm47暂无昵称, createdTime=Thu Jul 25 11:01:29 CST 2024, time=2024-07-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2213777, encodeId=22ef2213e7716, content=请问总共会邀请几个审稿人呀？我的第2个审稿人同意审稿了3个月都没回意见，今天又邀请了第3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4c1b5295017, createdName=14870713m77暂无昵称, createdTime=Sun Jul 07 22:14:44 CST 2024, time=2024-07-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216151, encodeId=69df22161511b, content=偏重的研究方向：生信<br>经验分享：显示两个人审都审完了快1个多月了，一直没后续，催了编辑也没用……咋整, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=frontiers, createdTime=Sun Jul 21 21:21:22 CST 2024, time=2024-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：影像组学;乳腺癌;病理组学<br>经验分享：<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了 同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212942, encodeId=62322212942b2, content=请问peer review期间系统时间变来变去什么意思呢，7 Jun为送外审日期，29 Jun变了一次，第二天又变成7 Jun了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e76402381, createdName=小小猫豆小豆, createdTime=Wed Jul 03 11:03:16 CST 2024, time=2024-07-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2212037, encodeId=08c7221203ebd, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：胰腺癌;标志物<br>经验分享：等的我延毕了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23b46513441, createdName=ms5000000153023119, createdTime=Fri Jun 28 07:32:17 CST 2024, time=2024-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床<br>经验分享：1月5日 peer review到现在5个月状态一直没变 中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省)]
    2024-01-23 ms5000000169069735 来自北京

    peer review两个月了

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2216888, encodeId=e076221688892, content=请问为啥送审回来修订以后还是只给传一个文稿文件，修订后不是得传修订版和最终版俩文件嘛，求怎么解决.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4d59144649, createdName=ms8000001805085068, createdTime=Thu Jul 25 22:43:38 CST 2024, time=2024-07-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216756, encodeId=881b2216e5652, content=请问现在是不能投稿了吗，为什么进不去提交不了？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a39b2533900, createdName=1250939fm47暂无昵称, createdTime=Thu Jul 25 11:01:29 CST 2024, time=2024-07-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2213777, encodeId=22ef2213e7716, content=请问总共会邀请几个审稿人呀？我的第2个审稿人同意审稿了3个月都没回意见，今天又邀请了第3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4c1b5295017, createdName=14870713m77暂无昵称, createdTime=Sun Jul 07 22:14:44 CST 2024, time=2024-07-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216151, encodeId=69df22161511b, content=偏重的研究方向：生信<br>经验分享：显示两个人审都审完了快1个多月了，一直没后续，催了编辑也没用……咋整, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=frontiers, createdTime=Sun Jul 21 21:21:22 CST 2024, time=2024-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：影像组学;乳腺癌;病理组学<br>经验分享：<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了 同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212942, encodeId=62322212942b2, content=请问peer review期间系统时间变来变去什么意思呢，7 Jun为送外审日期，29 Jun变了一次，第二天又变成7 Jun了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e76402381, createdName=小小猫豆小豆, createdTime=Wed Jul 03 11:03:16 CST 2024, time=2024-07-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2212037, encodeId=08c7221203ebd, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：胰腺癌;标志物<br>经验分享：等的我延毕了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23b46513441, createdName=ms5000000153023119, createdTime=Fri Jun 28 07:32:17 CST 2024, time=2024-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2208765, encodeId=67172208e6529, content=偏重的研究方向：肿瘤;临床<br>经验分享：1月5日 peer review到现在5个月状态一直没变 中途写邮件问，回复说在努力寻找审稿人..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2115690790, createdName=ms5000000721393428, createdTime=Fri Jun 07 10:24:45 CST 2024, time=2024-06-07, status=1, ipAttribution=四川省)]
    2024-06-07 ms5000000721393428 来自四川省

    偏重的研究方向：肿瘤;临床
    经验分享：1月5日 peer review到现在5个月状态一直没变 中途写邮件问，回复说在努力寻找审稿人...

    5

    展开5条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map